{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:13:13Z","timestamp":1793106793355,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"KWF Kankerbestrijding (NL)","award":["UM 2011-5020"],"award-info":[{"award-number":["UM 2011-5020"]}]},{"name":"KWF Kankerbestrijding (NL)","award":["UM 2009-4454"],"award-info":[{"award-number":["UM 2009-4454"]}]},{"name":"KWF Kankerbestrijding (NL)","award":["MAC 2013-6425"],"award-info":[{"award-number":["MAC 2013-6425"]}]},{"name":"KWF Kankerbestrijding (NL)","award":["MAC 2013-6089"],"award-info":[{"award-number":["MAC 2013-6089"]}]},{"name":"KWF Kankerbestrijding (NL)","award":["UM 2015-7635"],"award-info":[{"award-number":["UM 2015-7635"]}]},{"name":"ZonMw NGI Pre-Seed grant (NL)","award":["93612005"],"award-info":[{"award-number":["93612005"]}]},{"name":"Seventh Framework Programme (EU)","award":["222741"],"award-info":[{"award-number":["222741"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161040","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T17:56:00Z","timestamp":1470938160000},"page":"e0161040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy"],"prefix":"10.1371","volume":"11","author":[{"given":"Simon J. A.","family":"van Kuijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roben G.","family":"Gieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymon","family":"Niemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja G.","family":"Lieuwes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne","family":"Biemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Telfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido R. M. M.","family":"Haenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Yaromina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig J.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaye J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"M Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/14756366.2014.966704","article-title":"Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium","volume":"30","author":"EO Pettersen","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1089\/ars.2013.5378","article-title":"The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities","volume":"21","author":"JC Walsh","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2015.08.022","article-title":"New ways to image and target tumour hypoxia and its molecular responses","volume":"116","author":"LJ Dubois","year":"2015","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"P Ebbesen","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"RA Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"36","key":"ref7","doi-asserted-by":"crossref","first-page":"24204","DOI":"10.1074\/jbc.M109.006510","article-title":"Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response","volume":"284","author":"T van den Beucken","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","article-title":"Regulation of tumor pH and the role of carbonic anhydrase 9","volume":"26","author":"P Swietach","year":"2007","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"E Svastova","year":"2004","journal-title":"FEBS Lett"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"D Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fonc.2016.00069","article-title":"Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis","volume":"6","author":"SJ van Kuijk","year":"2016","journal-title":"Front Oncol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","article-title":"(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models","volume":"17","author":"SG Peeters","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2013.10.027","article-title":"Development and biological evaluation of (9)(9)mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers","volume":"71","author":"V Akurathi","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nucmedbio.2010.02.006","article-title":"Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia","volume":"37","author":"V Akurathi","year":"2010","journal-title":"Nucl Med Biol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation","volume":"99","author":"L Dubois","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.radonc.2013.06.018","article-title":"Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs","volume":"108","author":"L Dubois","year":"2013","journal-title":"Radiother Oncol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"SM Monti","year":"2013","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro","volume":"28","author":"RG Gieling","year":"2013","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"21","key":"ref19","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","author":"M Rami","year":"2013","journal-title":"J Med Chem"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(02)00927-0","article-title":"Chemotherapy for metastatic breast cancer-report of a European expert panel","volume":"3","author":"J Crown","year":"2002","journal-title":"Lancet Oncol"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro","volume":"66","author":"BP Mahoney","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"ref22","first-page":"1219","article-title":"Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents","volume":"66","author":"N Raghunand","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/mp200292c","article-title":"Drug resistance and cellular adaptation to tumor acidic pH microenvironment","volume":"8","author":"JW Wojtkowiak","year":"2011","journal-title":"Mol Pharm"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2007.04.018","article-title":"Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors","volume":"83","author":"L Dubois","year":"2007","journal-title":"Radiother Oncol"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"RG Gieling","year":"2012","journal-title":"J Med Chem"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"JY Winum","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref27","article-title":"Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models","author":"C Ward","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"ref28","first-page":"995","article-title":"Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells","volume":"24","author":"M Rafajova","year":"2004","journal-title":"Int J Oncol"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/1078-0432.CCR-15-0018","article-title":"TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging","volume":"21","author":"SG Peeters","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref30","first-page":"1","article-title":"Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells","author":"HH Hektoen","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2009.06.019","article-title":"Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model","volume":"92","author":"L Dubois","year":"2009","journal-title":"Radiother Oncol"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"e108068","DOI":"10.1371\/journal.pone.0108068","article-title":"Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model","volume":"9","author":"TW Meijer","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1021\/nn505895j","article-title":"Anticancer activity expressed by a library of 2,9-diazaperopyrenium dications","volume":"9","author":"KJ Hartlieb","year":"2015","journal-title":"ACS Nano"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.radonc.2010.07.007","article-title":"Effect of cetuximab and fractionated irradiation on tumour micro-environment","volume":"97","author":"A Santiago","year":"2010","journal-title":"Radiother Oncol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/09553000903232868","article-title":"Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts","volume":"85","author":"A Yaromina","year":"2009","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2006.08.010","article-title":"Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies","volume":"81","author":"A Yaromina","year":"2006","journal-title":"Radiother Oncol"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1158\/0008-5472.CAN-05-3295","article-title":"Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia","volume":"66","author":"M Franco","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"ref38","first-page":"2169","article-title":"Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity","volume":"24","author":"CJ Doillon","year":"2004","journal-title":"Anticancer Res"},{"issue":"2","key":"ref39","first-page":"125","article-title":"Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats","volume":"69","author":"K Nagai","year":"2014","journal-title":"Pharmazie"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e57554","DOI":"10.1371\/journal.pone.0057554","article-title":"Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness","volume":"8","author":"DM Eckman","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:52:16Z","timestamp":1589039536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161040"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161040","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}